|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
|
EP1409487A1
(en)
*
|
1999-09-15 |
2004-04-21 |
Warner-Lambert Company Llc |
Pteridinones as kinase inhibitors
|
|
WO2002018380A1
(en)
|
2000-08-31 |
2002-03-07 |
F. Hoffmann-La Roche Ag |
7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
|
|
WO2004063195A1
(en)
*
|
2003-01-03 |
2004-07-29 |
Sloan-Kettering Institute For Cancer Research |
Pyridopyrimidine kinase inhibitors
|
|
AU2004279427B2
(en)
*
|
2003-10-08 |
2008-07-03 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
EP1751136B1
(en)
|
2004-05-07 |
2014-07-02 |
Amgen Inc. |
Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
|
|
WO2006002367A1
(en)
*
|
2004-06-23 |
2006-01-05 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
|
EP1831215A1
(en)
*
|
2004-11-23 |
2007-09-12 |
Ranbaxy Laboratories Limited |
Pyrido[2,3-d]pyrimidines as anti-inflamatory agents
|
|
EP1846403A1
(en)
*
|
2005-02-02 |
2007-10-24 |
Ranbaxy Laboratories Limited |
Azabicyclo derivatives as anti-inflammatory agents
|
|
US7868177B2
(en)
|
2006-02-24 |
2011-01-11 |
Amgen Inc. |
Multi-cyclic compounds and method of use
|
|
US20090312321A1
(en)
*
|
2006-05-15 |
2009-12-17 |
Irm Llc |
Compositions and methods for fgf receptor kinases inhibitors
|
|
US7897762B2
(en)
*
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
JP2010509265A
(ja)
*
|
2006-11-09 |
2010-03-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
キナーゼ阻害剤としての置換６−フェニル−ピリド［２，３−ｄ］ピリミジン−７−オン誘導体及びそれの使用方法
|
|
CA2672518A1
(en)
|
2006-12-22 |
2008-07-03 |
Novartis Ag |
Organic compounds and their uses
|
|
CN102264728B
(zh)
|
2008-09-15 |
2015-02-04 |
加利福尼亚大学董事会 |
用于调节ire1、src和abl活性的方法和组合物
|
|
US9181238B2
(en)
*
|
2010-02-05 |
2015-11-10 |
Novartis Ag |
N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors
|
|
MX2014005296A
(es)
*
|
2011-11-04 |
2014-08-27 |
Afraxis Holdings Inc |
Inhibidores de pak para el tratamiento del sindrome del x fragil.
|
|
WO2013090840A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors
|
|
MX2015003874A
(es)
|
2012-09-26 |
2015-12-16 |
Univ California |
Modulacion de ire1.
|
|
US20140323477A1
(en)
*
|
2013-04-30 |
2014-10-30 |
Genentech, Inc. |
Serine/threonine kinase inhibitors
|
|
WO2014179496A1
(en)
*
|
2013-04-30 |
2014-11-06 |
Afraxis Holdings, Inc. |
Serine/threonine kinase inhibitors
|
|
WO2014182829A1
(en)
*
|
2013-05-09 |
2014-11-13 |
Principia Biopharma Inc. |
Quinolone derivatives as fibroblast growth factor inhibitors
|
|
EP3548476A4
(en)
*
|
2016-12-02 |
2020-05-20 |
Quentis Therapeutics, Inc. |
SMALL MOLECULAR IRE1 INHIBITORS
|
|
AR111281A1
(es)
|
2017-03-17 |
2019-06-26 |
Genentech Inc |
Compuestos de pirimidinil-piridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1
|
|
CA3064837A1
(en)
*
|
2017-06-01 |
2018-12-06 |
Quentis Therapeutics, Inc. |
Ire1 small molecule inhibitors
|
|
US10392367B2
(en)
|
2017-06-01 |
2019-08-27 |
Quentis Therapeutics, Inc. |
IRE1 small molecule inhibitors
|
|
WO2018222917A1
(en)
*
|
2017-06-01 |
2018-12-06 |
Quentis Therapeutics, Inc. |
Ire1 small molecule inhibitors
|
|
TWI831829B
(zh)
|
2018-09-12 |
2024-02-11 |
美商建南德克公司 |
苯氧基-吡啶基-嘧啶化合物及使用方法
|
|
EP3891137B1
(en)
|
2018-12-03 |
2024-10-09 |
Cornell University |
Ire1 small molecule inhibitors
|
|
JP7539892B2
(ja)
|
2019-01-03 |
2024-08-26 |
ジェネンテック， インコーポレイテッド |
癌疾患の処置のためのエンドリボヌクレアーゼのイノシトール要求酵素ｉ（ｉｒｅｉアルファ）の阻害剤としてのピリド－ピリミジノン化合物及びプテリジノン化合物
|
|
US10927111B2
(en)
|
2019-05-03 |
2021-02-23 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
|
KR102396930B1
(ko)
|
2020-01-15 |
2022-05-12 |
한국과학기술연구원 |
피리도[3,4-d]피리미딘 유도체 및 이를 포함하는 치료용 약학 조성물
|